STEREOCHEMICAL ASPECTS OF DRUGS

被引:0
|
作者
MILLER, DD [1 ]
机构
[1] OHIO STATE UNIV,COLL PHARM,DIV MED CHEM & PHARMACOGNOSY,COLUMBUS,OH 43210
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1984年 / 188卷 / AUG期
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:3 / CHED
相关论文
共 50 条
  • [31] SYNTHETIC AND STEREOCHEMICAL ASPECTS OF PHEROMONE CHEMISTRY
    MORI, K
    PURE AND APPLIED CHEMISTRY, 1994, 66 (10-11) : 1991 - 1998
  • [32] STEREOCHEMICAL ASPECTS OF ORGANOPHOSPHORUS ESTERASE INHIBITORS
    WU, SY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 40 - AGRO
  • [33] Stereochemical aspects in the chemistry of heterocyclic compounds
    M. A. Yurovskaya
    Chemistry of Heterocyclic Compounds, 2012, 48 : 683 - 683
  • [34] STEREOCHEMICAL ASPECTS OF ASTM STANDARDIZATION DEVELOPMENTS
    GRAGG, CE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 8 - CINF
  • [35] STEREOCHEMICAL ASPECTS OF CHLORINATED NORADRENALINE ANALOGS
    SQUIER, GJ
    VANDERSCHYF, CJ
    VENTER, DP
    OLIVER, DW
    VANROOYEN, PH
    DILLEN, JLM
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1985, 81 (06) : 338 - 338
  • [36] STEREOCHEMICAL ASPECTS OF REACTIONS OF ALKENYLIDENECYCLOPROPANES WITH PHENYLTRIAZOLINEDIONE
    PASTO, DJ
    BORCHARD.JK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1973, (AUG26): : 100 - 100
  • [37] STEREOCHEMICAL ASPECTS OF BACTERIAL POLYSACCHARIDE STRUCTURE
    RICHARDS, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 30 - CARB
  • [38] Glutamate Receptor Agonists: Stereochemical Aspects
    Vogensen, Stine Byskov
    Greenwood, Jeremy R.
    Bunch, Lennart
    Clausen, Rasmus Praetorius
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (07) : 887 - 906
  • [39] REACTIONS OF CANNABINOID TOSYLHYDRAZONES - STEREOCHEMICAL ASPECTS
    SREBNIK, M
    MECHOULAM, R
    TETRAHEDRON, 1984, 40 (19) : 3839 - 3843
  • [40] Pharmacological Importance of Stereochemical Resolution of Enantiomeric Drugs
    Mohamed R. Islam
    Jassem G. Mahdi
    Ivor D. Bowen
    Drug Safety, 1997, 17 : 149 - 165